Ionis Pharmaceuticals (IONS) reaffirms guidance

Ionis Pharmaceuticals (NASDAQ: IONS) is reaffirming its previously announced financial guidance for the fiscal year ending December 31, 2026, which remains unchanged from the financial guidance the Company provided on April 29, 2026 in its first quarter 2026 earnings release.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• Compass Point Starts Gorilla Tech Group/ (GRRR) at Buy
• Wendy's U.S. president to resign, company to create COO role